Cologuard® revenue increased 158 percent to $73 million during third quarter

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. META
5. TSLA
6. ISRG
7. SMCI
8. RTX
9. S
10. COF

Go back to Cologuard® revenue increased 158 percent to $73 million during third quarter

Exact Sciences (EXAS) PT Raised to $61 at Craig-Hallum

October 31, 2017 7:24 AM EDT

Craig-Hallum analyst Kevin Ellich raised his price target on Exact Sciences (NASDAQ: EXAS) to $61.00 while maintaining a Buy rating following strong beat and raise results.

... More

Exact Sciences (EXAS) Tops Q3 EPS by 7c; Guides Above Views

October 30, 2017 4:09 PM EDT

Exact Sciences (NASDAQ: EXAS) reported Q3 EPS of ($0.23), $0.07 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $72.6 million versus the consensus estimate of $65.02 million.

GUIDANCE:

Exact Sciences sees FY2017 revenue of $254-257 million, versus the consensus of... More